<img width="150" height="150" src="http://blogs.plos.org/speakingofmedicine/files/2014/09/Options-for-cost-sharing-DRAFT-v5-clean-150×150.jpg" alt="Figure notes:
Data in figures 1 and 3 were retrieved from World Bank Data http://data.worldbank.org/data-catalog/GDP-ranking-table
Data in figure 2 were retrieved from http://apps.who.int/nha/database/Select/Indicators/en
In figure 1, each income groups’ share of financing was calculated based on the aggregated GDP of all income groups. In figure 3, the GDP of the category “the rest of the world” was calculated by subtracting the other categories from World Bank’s estimated GDP for the World. This means that the reference GDP (the GDP of the world) is different in figure 1 and 3 (USD 72 725 856m vs USD 72 681 982m).
AUS: Australia; BRICS: Brazil, Russia, India, China and South Africa; CAN: Canada; CHE: Switzerland; EU: European Union; JPN: Japan; MIST: Mexico, Indonesia, South Korea and Turkey; NOR: Norway; USA: United States of America”>
The international community recently gave WHO a mandate to advance global health R&D by creating a pooled international fund for a first set of four Demonstration Projects. Mari Grepstad, Suerie Moon and John-Arne Røttingen consider how it could be funded.…
The post Who Should Contribute to Funding of Global Health R&D and How Much? appeared first on Speaking of Medicine.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.